Pacid (Pantoprazole Sodium Sesquihydrate)

Pantoprazole, the active ingredient in Pacid, is a proton pump inhibitor presented as a 40 mg tablet for oral use. It reduces gastric acid secretion and is used to treat conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults. GNH USA supplies Pacid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole is a proton pump inhibitor that acts on the acid‑production pathway of the stomach. It is indicated for several gastrointestinal conditions: - Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of erosive esophagitis. - Erosive esophagitis: heals mucosal damage caused by acid reflux. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls gastric acid hypersecretion associated with gastrin‑producing tumors.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: usually self‑limiting. - Nausea: occasional and transient. - Abdominal pain: mild discomfort. - Flatulence: excess gas. - Constipation: infrequent.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis. - Acute interstitial nephritis: renal inflammation. - Severe allergic reaction: rash, swelling, anaphylaxis. - Liver enzyme elevation: hepatitis signs. - Low magnesium levels: muscle cramps, arrhythmia. - Bone fracture risk: with long‑term use.

When prescribing Pantoprazole, clinicians should consider several safety aspects: - Assess renal function: dose adjustment may be needed in severe impairment. - Monitor magnesium: long‑term therapy can cause hypomagnesemia. - Evaluate bone health: prolonged use may increase fracture risk. - Review concomitant medications: potential for drug‑drug interactions. - Pregnancy and lactation: use only if clearly needed. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Pantoprazole can affect the pharmacokinetics of several medicines. Awareness of the interaction potential helps optimise therapy.

Major Interactions (Avoid): - Ketoconazole oral suspension: reduced absorption leading to therapeutic failure. - Atazanavir: markedly decreased plasma concentrations. - Warfarin: potential increase in anticoagulant effect.

Moderate Interactions (Monitor Closely): - Digoxin: modest increase in serum levels. - Methotrexate (high dose): reduced clearance may raise toxicity risk. - Clopidogrel: possible reduction in antiplatelet activity. - Iron salts: decreased iron absorption when taken simultaneously.